Molecules 2021, 26, 3974
16 of 17
References
1.
2.
3.
4.
5.
6.
7.
Arrowsmith, C.H.; Bountra, C.; Fish, P.V.; Lee, K.; Schapira, M. Epigenetic Protein Families: A New Frontier for Drug Discovery.
Nat. Rev. Drug Discov. 2012, 11, 384–400. [CrossRef]
Weichert, W. HDAC Expression and Clinical Prognosis in Human Malignancies. Cancer Lett. 2009, 280, 168–176. [CrossRef]
Marks, P.A.; Breslow, R. Dimethyl Sulfoxide to Vorinostat: Development of this Histone Deacetylase Inhibitor as an Anticancer
Su, G.H.; Sohn, T.A.; Ryu, B.; Kern, S.E. A Novel Histone Deacetylase Inhibitor Identified by High-Throughput Transcriptional
Screening of a Compound Library. Cancer Res. 2000, 60, 3137–3142.
Micelli, C.; Rastelli, G. Histone Deacetylases: Structural Determinants of Inhibitor Selectivity. Drug Discov. Today 2015, 20, 718–735.
Melesina, J.; Simoben, C.V.; Praetorius, L.; Bülbül, E.F.; Robaa, D.; Sippl, W. Strategies to Design Selective Histone Deacetylase
Inhibitors. ChemMedChem 2021. [CrossRef]
Porter, N.J.; Osko, J.D.; Diedrich, D.; Kurz, T.; Hooker, J.M.; Hansen, F.K.; Christianson, D.W. Histone Deacetylase 6-Selective
Inhibitors and the Influence of Capping Groups on Hydroxamate-Zinc Denticity. J. Med. Chem. 2018, 61, 8054–8060. [CrossRef]
8.
9.
Linciano, P.; Benedetti, R.; Pinzi, L.; Russo, F.; Chianese, U.; Sorbi, C.; Altucci, L.; Rastelli, G.; Brasili, L.; Franchini, S. Investigation
of the Effect of Different Linker Chemotypes on the Inhibition of Histone Deacetylases (HDACs). Bioorg. Chem. 2021, 106, 104462.
Thiehoff, C.; Rey, Y.P.; Gilmour, R. The Fluorine Gauche Effect: A Brief History. Israel J. Chem. 2017, 57, 92–100. [CrossRef]
10. Fox, S.J.; Gourdain, S.; Coulthurst, A.; Fox, C.; Kuprov, I.; Essex, J.W.; Skylaris, C.-K.; Linclau, B. A Computational Study of
Vicinal Fluorination in 2,3-Difluorobutane: Implications for Conformational Control in Alkane Chains. Chem. Eur. J. 2015, 21,
11. Tavasli, M.; O’Hagan, D.; Pearson, C.; Petty, M.C. The Fluorine Gauche Effect. Langmuir Isotherms Report the Relative
Conformational Stability of (±)-Erythro- and (±)-Threo-9,10-Difluorostearic Acids. Chem. Commun. 2002, 1226–1227. [CrossRef]
12. Fischer, S.; Huwyler, N.; Wolfrum, S.; Carreira, E.M. Synthesis and Biological Evaluation of Bromo- and Fluorodanicalipin A.
13. Yamamoto, I.; Jordan, M.J.T.; Gavande, N.; Doddareddy, M.R.; Chebib, M.; Hunter, L. The Enantiomers of Syn-2,3-Difluoro-4-
Aminobutyric Acid Elicit Opposite Responses at the GABAC Receptor. Chem. Commun. 2012, 48, 829–831. [CrossRef]
14. Hu, X.-G.; Thomas, D.S.; Griffith, R.; Hunter, L. Stereoselective Fluorination Alters the Geometry of a Cyclic Peptide: Exploration
of Backbone-Fluorinated Analogs of Unguisin A. Angew. Chem. Int. Ed. 2014, 53, 6176–6179. [CrossRef]
15. Au, C.; Gonzalez, C.; Leung, Y.C.; Mansour, F.; Trinh, J.; Wang, Z.; Hu, X.-G.; Griffith, R.; Pasquier, E.; Hunter, L. Tuning the
Properties of a Cyclic RGD-Containing Tetrapeptide through Backbone Fluorination. Org. Biomol. Chem. 2019, 17, 664–674.
16. Lizarme-Salas, Y.; Ariawan, A.D.; Ratnayake, R.; Luesch, H.; Finch, A.; Hunter, L. Vicinal Difluorination as a C=C Surrogate: An
Analog of Piperine with Enhanced Solubility, Photostability, and Acetylcholinesterase Inhibitory Activity. Beilstein J. Org. Chem.
17. Linclau, B.; Arda, A.; Reichardt, N.-C.; Sollogoub, M.; Unione, L.; Vincent, S.P.; Jimenez-Barbero, J. Fluorinated Carbohydrates
as Chemical Probes for Molecular Recognition Studies. Current Status and Perspectives. Chem. Soc. Rev. 2020, 49, 3863–3888.
18. Hofman, G.-J.; Ottoy, E.; Light, M.E.; Kieffer, B.; Kuprov, I.; Martins, J.C.; Sinnaeve, D.; Linclau, B. Minimising Conformational
Bias in Fluoroprolines through Vicinal Difluorination. Chem. Commun. 2018, 54, 5118–5121. [CrossRef] [PubMed]
19. Donohoe, T.J.; Lipin´ski, R.M. Interplay of Cascade Oxidative Cyclization and Hydride Shifts in the Synthesis of the ABC Spiroketal
Ring System of Pectenotoxin-4. Angew. Chem. Int. Ed. 2013, 52, 2491–2494. [CrossRef]
20. Nicoletti, M.; O’Hagan, D.; Slawin, A.M.Z. α,β,γ-Trifluoroalkanes: A Stereoselective Synthesis Placing Three Vicinal Fluorines
along a Hydrocarbon Chain. J. Am. Chem. Soc. 2005, 127, 482–483. [CrossRef]
21. CCDC 2084780 and 2084781 Contain the Crystallographic Information for Compounds 14 and 18 Respectively. Available online:
22. Gore, V.G.; Patil, M.S.; Bhalerao, R.A.; Mande, H.M.; Sandeep, G. Process for Preparation of Vorinostat. U.S. Patent 9162974B2, 20
October 2015.
0
23. Mai, A.; Esposito, M.; Sbardella, G.; Massa, S. A New Facile and Expeditious Synthesis of N-Hydroxy-N -Phenyloctanediamide, a
Potent Inducer of Terminal Cytodifferentiation. Org. Prep. Proced. Int. 2001, 33, 391–394. [CrossRef]
24. Barco, A.; Benetti, S.; Pollini, G.P.; Taddia, R. Synthesis of Cis-4-Octene-1,8-Dioic Acid and its Esters. Org. Prep. Proc. Int. 1974, 6,
25. Banik, S.M.; Medley, J.W.; Jacobsen, E.N. Catalytic, Diastereoselective 1,2-Difluorination of Alkenes. J. Am. Chem. Soc. 2016, 138,
26. Olszewska, B.; Kryczka, B.; Zawisza, A. Asymmetric Synthesis of Optically Active 2-Vinylpyrrolidines and 2-Vinylpiperidines by
Palladium-Catalysed Cyclisation of Amino Allylic Carbonates. Tetrahedron Lett. 2012, 53, 6826–6829. [CrossRef]
27. Patel, A.R.; Liu, F. Diastereospecific Fluorination of Substituted Azepanes. Tetrahedron 2013, 69, 744–752. [CrossRef]